Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2337572 | 1.00 | NPSR1 (0.32) | NPSR1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL18208987 | 0.89 | NPSR1 (0.34) | NPSR1MAPT | |
| SCHEMBL28540820 | 0.89 | NPSR1 (0.34) | NPSR1MAPT | |
| SCHEMBL31730819 | 0.84 | NPSR1 (0.32) | NPSR1ALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL25253267 | 0.82 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL29213559 | 0.79 | NPSR1 (0.33) | NPSR1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL1962926 | 0.76 | GRM4 (0.35) | ALDH1A1 | |
| SCHEMBL1963556 | 0.76 | NPSR1 (0.33) | NPSR1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL1962856 | 0.76 | NPSR1 (0.33) | NPSR1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL2340414 | 0.76 | NPSR1 (0.33) | NPSR1MAPTALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110207704-A1 | Novel Oxadiazole Compounds | ABBOTT LABORATORIES (US) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207704-A1 | Novel Oxadiazole Compounds | S1PR3, S1PR1, S1PR2 | NPSR1 472/4885MAPT 4556/4885ALDH1A1 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.